Department of Paediatric,Franck Joly Hospital,St-Laurent du Maroni,French Guiana,France.
Department of Clinical Biology,Franck Joly Hospital,St-Laurent du Maroni,French Guiana,France.
Epidemiol Infect. 2018 Jun;146(8):980-984. doi: 10.1017/S0950268818000912. Epub 2018 Apr 15.
French Guiana, a tropical country, is characterised by a young and multi-ethnic population. Difficulties in accessing safe water sources lead to outbreaks of gastroenteritis. The objectives of this study were (1) to describe the microbiological profile of shigella strains isolated in western French Guiana, including antimicrobial susceptibility and the distribution of strains in terms of species and serotypes and (2) to estimate the incidence of shigellosis in children under 5 years old. A retrospective observational study was conducted of 213 cases of shigellosis diagnosed in the biology department of the hospital centre for western French Guiana between 2000 and 2012 in children under 5 years old. The serogroups (formerly known as species) that predominates in French Guiana was Shigella flexneri. No resistance was observed to fluoroquinolones or to third-generation cephalosporins. The average incidence of shigellosis in children under 5 years old in western French Guiana was estimated at 189.6 cases per 100 000 inhabitants per year. Shigellosis is a public health problem in western French Guiana. These infections suggest the difficulties in accessing safe water sources and the lack of public sanitation. A quadrivalent vaccine containing Shigella sonnei and three serotypes of S. flexneri (S. flexneri 2a, 3a and 6) could provide broad coverage against shigella infections.
法属圭亚那是一个热带国家,其人口特点是年轻且多族裔。由于难以获得安全的水源,导致肠胃炎爆发。本研究的目的是:(1) 描述在法属圭亚那西部分离出的志贺氏菌菌株的微生物特征,包括对各种抗菌药物的敏感性,以及按种和血清型分布;(2) 估计 5 岁以下儿童的志贺氏菌病发病率。我们对 2000 年至 2012 年间在法属圭亚那西部医院中心生物学系诊断的 213 例 5 岁以下儿童志贺氏菌病病例进行了回顾性观察性研究。法属圭亚那最常见的血清群(以前称为种)是福氏志贺菌。未观察到对氟喹诺酮类或第三代头孢菌素类药物的耐药性。法属圭亚那西部 5 岁以下儿童志贺氏菌病的平均发病率估计为每年每 10 万人 189.6 例。志贺氏菌病是法属圭亚那西部的一个公共卫生问题。这些感染表明难以获得安全的水源和缺乏公共卫生设施。含有宋内志贺菌和三种福氏志贺菌血清型(福氏志贺菌 2a、3a 和 6)的四价疫苗可以提供针对志贺氏菌感染的广泛保护。